Clinical TrialsSearch results
Number of results: 314
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Recruiting
- A novel treatment for ulcerative colitis with purastat
- Ulcerative colitis
- Hashimoto Yu
- 2023-06-07
Other
- Phase II study of oral S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer
- Locally Advanced Non-Small Cell Lung Cancer
- Gunma University Hospital
- 2009-03-03
Other
- Phase II study of amrubicin for previously treated advanced non-small cell lung cancer
- Recurrent non-small cell lung cancer
- Gunma University Hospital
- 2009-03-05
Other
- A phase II study of gemcitabine and TS-1 in erderly patients with advanced non-small cell lung cancer
- Advanced non-small cell lung cancer
- Gunma University Hospital
- 2009-03-05
Other
- A phase II study of CBDCA and TS-1 in patients with advanced non-small cell lung cancer
- Advanced non-small cell lung cancer
- Gunma University Hospital
- 2009-03-03
Other
- A phase II study of amrubicin for previously treated small cell lung cancer
- For patients with recurrent small cell lung cancer
- Gunma University Hospital
- 2009-03-05
Other
- Treatment efficacy of pegintron alpha-2b and rivavirin for chronic hepatitis C patients with genotype 2 and high viral loads based on the dissapearance speed of serum HCV-RNA
- chronic hepatitis C with genotype 2 and high viral loads
- Gunma Liver Study Group (GLSG)
- 2012-12-31
Other
- Tenofovir for the treatment of breakthrough hepatitis caused by lamivudine and adefovir dipivoxil-resistant mutants of hepatitis B virus
- chronic hepatitis B
- Gunma Liver Study Group (GLSG)
- 2012-10-01